UBS AM Portfolio holdings
UBS AM is the US asset manager of UBS and grew out of Brinson Partners, an investment firm founded by Gary Brinson and made independent in 1989. Swiss Bank Corporation bought Brinson Partners in 1994, and once the bank merged with UBS, its founder Gary Brinson, who had run Swiss Bank's asset management business, became chief investment officer of UBS Asset Management. In 2024 the business took in Credit Suisse Asset Management and two of its own units, UBS Hedge Fund Solutions and UBS O’Connor, though the O’Connor business was later sold. Its clients are mainly institutions such as retirement plans, government bodies, endowments and foundations.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Equinix
EQIX
|
+$1.32B |
| 2 |
Digital Realty Trust
DLR
|
+$931M |
| 3 |
Western Digital
WDC
|
+$895M |
| 4 |
Simon Property Group
SPG
|
+$736M |
| 5 |
Realty Income
O
|
+$643M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$1.73B |
| 2 |
Eaton
ETN
|
+$1.21B |
| 3 |
Seagate
STX
|
+$1.1B |
| 4 |
Trane Technologies
TT
|
+$1.02B |
| 5 |
Accenture
ACN
|
+$1.01B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 40.05% |
| 2 | Financials | 11.12% |
| 3 | Healthcare | 9.54% |
| 4 | Consumer Discretionary | 9.09% |
| 5 | Communication Services | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2351
Alexander's
ALX
$1.29B
| $881K | ﹤0.01% |
3,196
-30
| -0.9% | -$7.49K |
2024 Q2
8 quarters
|
|
2352
Diversified Energy Company
DEC
$997M
| $880K | ﹤0.01% |
63,474
| – | – |
2025 Q4
2 quarters
|
|
2353
Hovnanian Enterprises
HOV
$592M
| $878K | ﹤0.01% |
6,166
| – | – |
2024 Q2
8 quarters
|
|
2354
Prudential
PUK
$30.2B
| $873K | ﹤0.01% |
32,568
-21
| -0.1% | -$613 |
2025 Q4
2 quarters
|
|
2355
Allient
ALNT
$1.46B
| $862K | ﹤0.01% |
8,372
| – | – |
2025 Q4
2 quarters
|
|
2356
Opko Health
OPK
$1.24B
| $861K | ﹤0.01% |
574,107
-100,741
| -15% | -$128K |
2013 Q2
52 quarters
|
|
2357
Pulse Biosciences
PLSE
$3.73B
| $855K | ﹤0.01% |
30,817
-1,003
| -3% | -$23.7K |
2024 Q3
7 quarters
|
|
2358
Dr. Reddy's Laboratories
RDY
$11.8B
| $854K | ﹤0.01% |
58,932
+35,470
| +151% | +$479K |
2021 Q2
20 quarters
|
|
2359
U-Haul Holding Co
UHAL
$11.2B
| $853K | ﹤0.01% |
13,036
+2,869
| +28% | +$157K |
2025 Q2
4 quarters
|
|
2360
InterContinental Hotels
IHG
$24.5B
| $851K | ﹤0.01% |
4,916
| – | – |
2025 Q4
2 quarters
|
|
2361
First Community Bankshares
FCBC
$888M
| $842K | ﹤0.01% |
18,949
-534
| -3% | -$22.9K |
2021 Q1
21 quarters
|
|
2362
First Trust Dow Jones Internet Index Fund ETF
FDN
$4.83B
| $835K | ﹤0.01% |
3,155
-29
| -0.9% | -$7.66K |
2025 Q4
2 quarters
|
|
2363
Energy Vault
NRGV
$562M
| $834K | ﹤0.01% |
177,171
+149,866
| +549% | +$670K |
2026 Q1
1 quarter
|
|
2364
Atlanta Braves Holdings Series A
BATRA
$3.51B
| $831K | ﹤0.01% |
14,759
| – | – |
2022 Q3
15 quarters
|
|
2365
Aveanna Healthcare
AVAH
$2.87B
| $831K | ﹤0.01% |
96,956
+14,492
| +18% | +$102K |
2024 Q4
6 quarters
|
|
2366
RELX
RELX
$69.6B
| $826K | ﹤0.01% |
26,066
-32
| -0.1% | -$1.08K |
2025 Q4
2 quarters
|
|
2367
CytomX Therapeutics
CTMX
$510M
| $824K | ﹤0.01% |
219,779
+30,379
| +16% | +$116K |
2026 Q1
1 quarter
|
|
2368
BKV Corp
BKV
$2.29B
| $823K | ﹤0.01% |
30,084
+8,144
| +37% | +$224K |
2025 Q4
2 quarters
|
|
2369
ODDITY Tech
ODD
$1000M
| $820K | ﹤0.01% |
54,226
-8,310
| -13% | -$111K |
2025 Q4
2 quarters
|
|
2370
CNA Financial
CNA
$13.2B
| $816K | ﹤0.01% |
16,794
| – | – |
2017 Q1
37 quarters
|
|
2371
Groupon
GRPN
$640M
| $811K | ﹤0.01% |
33,723
| – | – |
2025 Q2
4 quarters
|
|
2372
NB Bancorp
NBBK
$970M
| $811K | ﹤0.01% |
38,359
-1,003
| -3% | -$20.6K |
2024 Q3
7 quarters
|
|
2373
McEwen Inc
MUX
$861M
| $808K | ﹤0.01% |
44,568
-1,000
| -2% | -$21.6K |
2025 Q4
2 quarters
|
|
2374
WisdomTree US MidCap Dividend Fund
DON
$3.99B
| $805K | ﹤0.01% |
14,238
-68
| -0.5% | -$3.75K |
2025 Q4
2 quarters
|
|
2375
Vanguard Morningstar Mega Cap Growth ETF
MGK
$32.7B
| $797K | ﹤0.01% |
9,063
-42,537
| -82% | -$3.63M |
2025 Q4
2 quarters
|
|
Similar funds
UBS AM's Q2 2026 Portfolio in Review
As of Q2 2026, UBS AM held 3,886 positions worth $550B, up 14% from $481B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
UBS AM's Q2 2026 filing shows 45 new, 996 increased, 1,636 reduced and 163 closed positions. Its largest new stake was Honeywell Aerospace: 1,676,062 shares worth $371M. The largest sale was Linde, an estimated $1.73B.
By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 35% a quarter earlier, followed by Financials and Healthcare.
- UBS AM's largest Q2 2026 buy was Honeywell Aerospace: 1,676,062 shares worth $371M.
- UBS AM added most to Equinix in Q2 2026, an estimated $1.32B increase.
- UBS AM's biggest Q2 2026 reduction was Linde, cutting an estimated $1.73B.
- UBS AM fully exited Hologic in Q2 2026, selling an estimated $174M.
- UBS AM's ten largest holdings make up 33% of its $550B portfolio in Q2 2026.
- UBS AM opened 45 new positions and closed 163 in Q2 2026.
- UBS AM's portfolio value rose 14% quarter-over-quarter to $550B.
Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.